Isomorphic Labs raises $5B as it looks to take drug candidates to clinical trials
Isomorphic Labs, the AI drug-discovery platform that was spun out of Google’s DeepMind in 2021, has raised $5 billion in a Series C funding round.
Isomorphic Labs, the AI drug-discovery platform that was spun out of Google’s DeepMind in 2021, has raised $5 billion in a Series C funding round.
Research finds that leading AI models developed by Chinese companies may have used Nvidia chips restricted for export by the US government. This indicates challenges in Nvidia's chip design. Models released by companies like DeepSeek and Moonshot AI may be affected by the embargoed chips. Epoch AI estimates that about 2 million advanced chips entered China in 2024 and 2025, including 275,000 Nvidia AI accelerators entering Malaysia.